By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Chimerix, Inc. 

2505 Meridian Parkway
Ste 340
Durham  North Carolina  27713  U.S.A.
Phone: 919-806-1074 Fax: 919-806-1146



Company News
More Bad News for Chimerix (CMRX) as Brincidofovir Fails Another Late Stage Study 5/9/2016 7:59:57 AM
North Carolina Biotechs Like Chimerix (CMRX), Heat Biologics Desperately Seek Funding in Down Market 3/28/2016 7:01:31 AM
Multiple Failed Trials Lead Chimerix (CMRX) to Slash 20% of Workforce 3/1/2016 6:37:46 AM
After Shelving Three Phase III Studies, Chimerix (CMRX) May Have Become a Takeover Target 2/24/2016 6:05:36 AM
Chimerix (CMRX) To Announce Fourth Quarter And Full Year 2015 Financial Results On February 29, 2016 2/23/2016 8:13:12 AM
Chimerix (CMRX) Stock Plunges Again After Company Abandons Two More Phase III Trials 2/22/2016 6:48:15 AM
Chimerix (CMRX) To Present At The 34th Annual J.P. Morgan Healthcare Conference 1/5/2016 8:30:51 AM
Down But Not Out Chimerix (CMRX) CEO Berrey Charts Future For Drug Developer 12/31/2015 1:40:08 PM
Hedge Fund Manager Steven Cohen Reports 5.3% Stake in Chimerix (CMRX) 12/31/2015 11:22:28 AM
Chimerix (CMRX) Shares Plunge After Brincidofovir Fails in Phase III Trial 12/28/2015 6:17:20 AM